Skip to main content

Multiple Sclerosis Mimics

  • Chapter
  • First Online:
  • 1189 Accesses

Abstract

Although the course of the disease in all MS patients is different, most MS patients present in fairly straightforward manner, so that the diagnosis is usually made soon after first presentation to a neurologist. However, sometimes the diagnosis is incorrect, either because the patient has another disease process and MS is mistakenly diagnosed, or less commonly because the patient has MS and another diagnosis is erroneously made. This chapter discusses the diseases that most commonly mimic MS. The confusion usually occurs at the time of the first neurological event, clinically isolated syndrome (CIS), rather than in patients who have had previous events. CIS, as previously discussed in Chaps. 4 and 5, is the sudden development of a demyelinating and inflammatory event, consistent with a first attack of MS, that does not meet criteria for clinically definite MS. Thus, optic neuritis or myelitis or a hemisensory syndrome in a young, previously healthy individual might be CIS or one of the other diseases outlined in the chapter. If the patient with CIS develops new MRI lesions or has new attacks, the diagnosis of MS is much less difficult. Some issues and difficulties involved in differential diagnosis of the CIS patient are highlighted in a recent clinical review of six German patients with CIS [2]. Some examples of diseases that have clinical, imaging, or CSF characteristics similar to MS are summarized in Table 6.1. Finally, not all symptoms localizing to the CNS in patients with known MS should automatically be assumed to be a new attack of MS, as exemplified by the patient in Inset 6.1.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Costello DJ, Eichler AF, Eichler FS. Leukodystrophies: classification, diagnosis, and treatment. Neurologist. 2009;15(6):319–28.

    Article  PubMed  Google Scholar 

  2. Tumani H, Sapunova-Mayer I, Sussmuth SD, Hirt V, Brettschneider J. CIS case studies. J Neurol Sci. 2009;287 Suppl 1:S7–10.

    Article  PubMed  Google Scholar 

  3. Brain WR, Walton JN. Diseases of the nervous system. 7th ed. New York: Oxford University Press; 1969.

    Google Scholar 

  4. Murray TJ. Multiple sclerosis: the history of a disease. 1st ed. New York: Demos; 2005.

    Google Scholar 

  5. Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 2007;6(6):544–52.

    Article  PubMed  Google Scholar 

  6. Pandit L. Differential diagnosis of white matter diseases in the tropics: an overview. Ann Indian Acad Neurol. 2009;12(1):12–21.

    PubMed  Google Scholar 

  7. Collongues N, Marignier R, Zephir H, et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology. 2010;74(9):736–42.

    Article  PubMed  CAS  Google Scholar 

  8. Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66(5):617–29.

    Article  PubMed  CAS  Google Scholar 

  9. Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009;66(5):630–43.

    Article  PubMed  CAS  Google Scholar 

  10. Jacob A, Matiello M, Weinshenker BG, et al. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009;66(9):1128–33.

    Article  PubMed  Google Scholar 

  11. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Treat Options Neurol. 2008;10(1):55–66.

    Article  PubMed  Google Scholar 

  12. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000;123(Pt 12):2407–22.

    Article  PubMed  Google Scholar 

  13. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM. 2009;102(7):449–60.

    Article  PubMed  CAS  Google Scholar 

  14. Vasconcelos OM, Poehm EH, McCarter RJ, Campbell WW, Quezado ZMN. Potential outcome factors in subacute combined degeneration. J Gen Intern Med. 2006;21:1063.

    Article  PubMed  Google Scholar 

  15. Susac JO, Egan RA, Rennebohm RM, Lubow M. Susac’s syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci. 2007;257(1–2):270–2.

    Article  PubMed  Google Scholar 

  16. Vickrey BG, Samuels MA, Ropper AH. How neurologists think: a cognitive psychology perspective on missed diagnoses. Ann Neurol. 2010;67(4):425–33.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Pachner, A.R. (2012). Multiple Sclerosis Mimics. In: A Primer of Neuroimmunological Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-2188-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-2188-7_6

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-2187-0

  • Online ISBN: 978-1-4614-2188-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics